$AVNR Headlines U.S. stock futures cut rise after retail

New Post Public Reply Private Reply Replies (0) Message Board

Dec 27, 2013 at 11:46 AM

$AVNR Headlines

U.S. stock futures cut rise after retail sales 7:53 a.m. Aug. 13, 2013 - Barbara Kollmeyer
Cree, Flowers Foods in focus Tuesday 7:42 a.m. Aug. 13, 2013 - Wallace Witkowski
Yum Brands shares drop on sour China sales 4:23 p.m. Aug. 12, 2013 - Wallace Witkowski
Avanir to promote Merck's diabetes drug Januvia 3:48 p.m. Aug. 12, 2013 - MarketWatch.com
Avanir shares rise after hours on license deal 5:29 p.m. July 2, 2013 - Wallace Witkowski
Avanir, OptiNose enter N. America licensing deal 4:27 p.m. July 2, 2013 - MarketWatch.com
7 gut checks before the stock market's opening bell 5:43 a.m. April 29, 2013 - Shawn Langlois
Avanir Pharmaceuticals shares down 3% 9:37 a.m. Nov. 17, 2010 - Nick Godt
Monday’s biggest gaining and declining stocks 4:25 p.m. Nov. 1, 2010 - Laura Mandaro
Avanir and Allergan lead drug stocks 12:55 p.m. Nov. 1, 2010 - Val Brickates Kennedy
Avanir leads drug stocks north 9:06 a.m. Nov. 1, 2010 - Val Brickates Kennedy
Rexahn, Avanir gain; Sequenom falls 12:32 p.m. April 7, 2010 - Val Brickates Kennedy
Avanir, Opexa gain ahead of presentations 2:16 p.m. April 6, 2010 - Val Brickates Kennedy
Avanir shares jump 10% in pre-market action 8:27 a.m. April 6, 2010 - Val Brickates Kennedy
Drug stocks pressured by J&J report; Avanir jumps 12:49 p.m. Oct. 13, 2009 - Val Brickates Kennedy
Avanir, Acorda move on MS drug updates 2:51 p.m. Oct. 9, 2009 - Val Brickates Kennedy
Tuesday's biggest gaining and declining stocks 5:10 p.m. Aug. 11, 2009 - MarketWatch
Avanir soars and Javelin sinks on drug studies 12:15 p.m. Aug. 11, 2009 - Val Brickates Kennedy
Avanir Pharmaceuticals shares up 85% 8:41 a.m. Aug. 11, 2009 - Nick Godt
Avanir climbs on Phase III Zenvia trial success 6:31 a.m. Aug. 11, 2009 - Steve Goldstein

Interesting AVNR Put And Call Options For February 2014 11:44 a.m. Dec. 24, 2013 - TheStreet.com
Perilous Reversal Stock: AVANIR Pharmaceuticals (AVNR) 12:03 p.m. Dec. 23, 2013 - TheStreet.com
Avanir Pharmaceuticals (AVNR) Jumps: Stock Up 19.7% - Tale of the Tape 8:51 a.m. Dec. 23, 2013 - Zacks.com
Look For These Biotech Stocks To Move In 2014 11:14 a.m. Dec. 19, 2013 - Seeking Alpha
Mid-Afternoon Market Update: Markets Falling as Smith & Wesson Continues to Rise on Earnings 3:02 p.m. Dec. 11, 2013 - benzinga.com
Mid-Day Market Update: Smith & Wesson Gains On Upbeat Profit; LabCorp Shares Decline 11:29 a.m. Dec. 11, 2013 - benzinga.com
Summer Street defends Avanir after trial miss 10:38 a.m. Dec. 11, 2013 - Seeking Alpha
Mid-Morning Market Update: Markets Fall; Joy Global Profit Misses Estimates 10:37 a.m. Dec. 11, 2013 - benzinga.com
Avanir Reports Wider Loss - Analyst Blog 10:37 a.m. Dec. 11, 2013 - Zacks.com
Zacks #5 Rank Additions for Wednesday - Tale of the Tape 9:30 a.m. Dec. 11, 2013 - Zacks.com
Morning Market Losers 9:05 a.m. Dec. 11, 2013 - benzinga.com
Benzinga's Top #PreMarket Losers 7:34 a.m. Dec. 11, 2013 - benzinga.com
Benzinga's Top Downgrades 7:13 a.m. Dec. 11, 2013 - benzinga.com
Wednesday’s Biggest Stock Losers – AVNR, OPK and More 6:19 a.m. Dec. 11, 2013 - InvestorPlace.com
10-K: AVANIR PHARMACEUTICALS, INC. 6:09 a.m. Dec. 11, 2013 - Edgar Online - (EDG = 10Q, 10K)
Avanir's CEO Discusses F4Q 2013 Results - Earnings Call Transcript 8:08 p.m. Dec. 10, 2013 - Seeking Alpha
Avanir -13.8% AH, AVP-923 misses primary efficacy endpoint in phase II trial 5:36 p.m. Dec. 10, 2013 - Seeking Alpha
Q4 2013 AVANIR PHARMACEUTICALS Earnings Conference call (Webcast) 4:25 p.m. Dec. 10, 2013 - Seeking Alpha
Earnings Scheduled For December 10, 2013 4:14 a.m. Dec. 10, 2013 - benzinga.com
An Analysis Into Avanir Pharmaceuticals Neutralizes Concern And Reveals Potential 10:44 a.m. Dec. 9, 2013 - Seeking Alpha

SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Avanir Pharmaceuticals, Inc. Regarding Possible Breaches of Fiduciary Duty 4:13 p.m. Dec. 24, 2013 - PR Newswire
Public Offerings, Merger Agreements, New Preclinical Data, New Treatments and Dividend Payments - Research Report on XOMA, MAKO, Alnylam, Avanir, and PDL BioPharma 8:00 a.m. Dec. 18, 2013 - PR Newswire
Technical Research on Equities: Zoetis, Actavis, Avanir Pharma, and Salix Pharma 8:00 a.m. Dec. 16, 2013 - PR Newswire
Quarterly Dividends, Clinical Trial Results, Dental Exhibition Updates, and Upcoming Presentation Schedules - Research Report Quest Diagnostics, Avanir, Sirona, Ligand and Genomic Health 8:00 a.m. Dec. 16, 2013 - PR Newswire
Important Stocks Scan List: Nokia Corporation, BlackBerry Ltd, Sprint Corporation, Avanir Pharmaceuticals 9:02 a.m. Dec. 11, 2013 - ACCESSWIRE
Avanir Pharmaceuticals Announces Results for Phase II PRIME Study 4:00 p.m. Dec. 10, 2013 - PR Newswire
Avanir Pharmaceuticals Reports Fiscal 2013 Fourth Quarter Financial and Year-End Business Results 4:00 p.m. Dec. 10, 2013 - PR Newswire
Avanir Pharmaceuticals Announces Date of Fiscal 2013 Fourth Quarter Financial Results and Conference Call 8:00 a.m. Dec. 3, 2013 - GlobeNewswire
Avanir Pharmaceuticals to Participate in Two Conferences in December 8:30 a.m. Nov. 26, 2013 - PR Newswire
Stock Price Update, Recognitions, and Grant of Stock Options - Research Report on Cyberonics, Hill-Rom Holdings, Bio-Reference Laboratories, Avanir Pharmaceuticals, and ImmunoGen 8:00 a.m. Nov. 21, 2013 - PR Newswire
Before the Bell Scans: Zoetis Inc., Avanir Pharma, Actavis PLC, and Salix Pharmaceuticals Ltd 8:01 a.m. Nov. 13, 2013 - PR Newswire
Preliminary Financial Results, Quarterly Reports and Upcoming Conference Schedules - Research Report on Avanir, BioScrip, Chemed, Foundation Medicine, and Antares 8:00 a.m. Nov. 11, 2013 - PR Newswire
Avanir Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 4:00 p.m. Nov. 8, 2013 - PR Newswire
Avanir Pharmaceuticals Pre-Announces Preliminary Fiscal 2013 Year End Financial Information 8:30 a.m. Oct. 29, 2013 - PR Newswire
Recognitions, Patent Issuance, Financial Results, Upcoming Investor Conferences and Update on ClinicalTrial - Research Report on Stereotaxis, Immunomedics, Novadaq, Avanir, and Raptor Pharmaceuticals 9:00 a.m. Oct. 28, 2013 - PR Newswire
Technical Study: Zoetis Inc., AVANIR Pharma Inc., Actavis plc, and Salix Pharma Ltd 9:18 a.m. Oct. 24, 2013 - PR Newswire
Avanir Pharmaceuticals to Host Investor Day on October 29, 2013 8:30 a.m. Oct. 23, 2013 - PR Newswire
Avanir Pharmaceuticals Announces Enrollment of First Patient in Study of AVP-923 for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease 8:30 a.m. Oct. 22, 2013 - PR Newswire
Avanir Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 4:15 p.m. Oct. 4, 2013 - PR Newswire
Today's Technical View: Avanir Pharmaceuticals Inc., Warner Chilcott PLC, Actavis Inc., and Dynavax Technologies Corp. 11:48 a.m. Oct. 1, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

7-Eleven Rolls Out Korean Flavors in Bold Menu Shift

7-Eleven's New Global Menu Twist October 2026 sees 7-Eleven, Inc. whip out an intriguing move, venturing east with its new Flavors of Korea menu. They're not just changing the game in convenience store aisles; they're dancing to the beat of global flavors—a shake-up fit for the world's largest convenience retailer. Think about bodega basics getting a spicy Korean...

Air Force Enlisted Village: Trailblazing Senior Care

Changing the Senior Living Game for Military Families Out of all the fancy talk shows and slick productions, "All Access hosted by Andy Garcia" managed to hit a real nerve on the quiet, critical shifts happening in the senior living sector. They dug into how Air Force Enlisted Village in Shalimar is taking care of our military families' unsung heroes—the surviving...

JELD-WEN Kicks Off 2027 Senior Notes Exchange

By Caleb Price Updated Oct 28, 2026 Category News Views 164

A Fresh Play: Swapping Old for New With a fresh brew in hand and the latest company maneuvers on the table, JELD-WEN's move to exchange its 4.875% Senior Notes due 2027 for new secured notes maturing in 2031 comes into focus. This ain't just some routine shuffling of papers. They're calling up eligible folks holding onto those old notes, saying, 'Why stick with the old...

Max Stock Gears Up for Q3 Earnings Report Nov. 17

Max Stock's Q3 Earnings Anticipation Ah, it’s that time again—when we wait with bated breath for another round of quarterly earnings. Max Stock Ltd. (TASE: MAXO) is prepping to spill the beans on their third quarter 2026 performance, with a conference call scheduled for November 17. Big day? You bet. Who's Leading the Call? The brains behind the operation, CFO Paz Oz...

Aker BP's Q3 2026: Strong Earnings Fuel Optimism

Third Quarter Overview: Riding the Wave Aker BP's third quarter report is a raucous symphony of successes that have the market nodding in admiration. Marking significant strides with their offshore projects, the company seems to be in a cavalier mood as it boasts higher sales volumes and promising financials. Net production came in at 374 mboepd, dampened slightly by...

Pencil Reinvention Aims to Reduce Classroom Waste

Sharpen Those Ideas: Reinventing the Humble Pencil Every classroom has 'em: pencils chewed up faster than a kid chomping through bubblegum. This ain't new. But dig this—a Chicago teacher's coming in hot with a tweak to extend pencil life. How? By addressing the ol' crumbly eraser issue. You know, the kind that vanishes into thin air right when you need it most. So,...

Life Time's Q3 2026 Results Highlight Solid Growth

Life Time Rolls On With Strong Q3 Performance Sometimes the market hands you pure gold, and that's what Life Time (NYSE: LTH) has right now. They didn't just have a decent quarter; they outright nailed it with a $893.5 million total revenue haul—a hefty 14.2% rise from the prior year. What's driving this ship? Solid growth in membership dues and dynamic personal...

Bitcoin Mortgages: APX Ushers in New Canadian Era

Bitcoin Meets Canadian Mortgages: A Game Changer? Here's a scenario you didn't see coming: Bitcoin, the digital darling of the new millennium, now backing Canadian mortgages. If that doesn't get your financial senses tingling, maybe you haven't been paying attention. APX Lending, a pioneer in digital-asset-backed lending, is kicking open the doors to a fresh financial...

Cohere's CAD $7 Billion Raise Signals AI Power Shift

Changing the Game: Cohere's Massive Series E Raise There's a seismic shift happening up north, and it’s not the aurora borealis. Cohere just announced the initial close of a staggering CAD $7 billion Series E funding round, eyeing a CAD $35.7 billion valuation. If it pans out, it’d be the kind of cash grab that's never been seen in Canadian tech history. Why This...

CallRail's New Insight Tool: Navigating the Competitive Landscape

How CallRail's New Feature Changes the Game Ever sit in a boardroom meeting and wonder what your lead numbers really mean? CallRail just dropped a new feature that could change that. This AI-powered platform is now decking its 225,000 businesses with market insights to not just know their numbers but to understand how they stack up against their competition in the same...